Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma
Clinical trial NCT02336425 · TERMINATED
Trial details
- NCT number
- NCT02336425
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.